Second AKT: The rise of SGK in cancer signalling

References

• Alliston TN, Maiyar AC, Buse P, Firestone GL, Richards JS. 1997. Follicle stimulating hormone-regulated expression of serum/glucocorticoid-inducible kinase in rat ovarian granulosa cells: A functional role for the Sp1 family in promoter activity. Mol Endocrinol. 11:1934–1949.
   PubMedGoogle Scholar
• Alonso L, Okada H, Pasolli HA, Wakeham A, You-Ten AI, Mak TW, Fuchs E. 2005. Sgk3 links growth factor signaling to maintenance of progenitor cells in the hair follicle. J Cell Biol. 170:559–570.
   PubMed Web of Science ®Google Scholar
• Altomare DA, Testa JR. 2005. Perturbations of the AKT signaling pathway in human cancer. Oncogene. 24:7455–7464.
   PubMed Web of Science ®Google Scholar
• Amato R, D'Antona L, Porciatti G, Agosti V, Menniti M, Rinaldo C, Costa N, Bellacchio E, Mattarocci S, Fuiano G, Soddu S, Paggi MG, Lang F, Perrotti N. 2009. Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation. J Mol Med. 87 12: 39–1221Dec–Eub.
   Web of Science ®Google Scholar
• Aoyama T, Matsui T, Novikov M, Park J, Hemmings B, Rosenzweig A. 2005. Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response. Circulation. 111:1652–1659.
   PubMed Web of Science ®Google Scholar
• Aronova S, Wedaman K, Aronov PA, Fontes K, Ramos K, Hammock BD, Powers T. 2008. Regulation of ceramide biosynthesis by TOR complex 2. Cell Metab. 7:148–158.
   PubMedGoogle Scholar
• Arteaga MF, Wang L, Ravid T, Hochstrasser M, Canessa CM. 2006. An amphipathic helix targets serum and glucocorticoid-induced kinase 1 to the endoplasmic reticulum-associated ubiquitin-conjugation machinery. Proc Natl Acad Sci USA. 103:11178–11183.
   PubMed Web of Science ®Google Scholar
• Arteaga MF, Alvarez de la Rosa D, Alvarez JA, Canessa CM. 2007. Multiple translational isoforms give functional specificity to serum- and glucocorticoid-induced kinase 1. Mol Biol Cell. 18:2072–2080.
   PubMed Web of Science ®Google Scholar
• Baldwin A, Grueneberg DA, Hellner K, Sawyer J, Grace M, Li W, Harlow E, Munger K. 2010. Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3. Proc Natl Acad Sci USA. 107:12463–12468.
   PubMed Web of Science ®Google Scholar
• BelAiba RS, Djordjevic T, Bonello S, Artunc F, Lang F, Hess J, Gorlach A. 2006. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: Role in redox-sensitive regulation of tissue factor by thrombin. Circ Res. 98:828–836.
   PubMed Web of Science ®Google Scholar
• Bell LM, Leong ML, Kim B, Wang E, Park J, Hemmings BA, Firestone GL. 2000. Hyperosmotic stress stimulates promoter activity and regulates cellular utilization of the serum- and glucocorticoid-inducible protein kinase (Sgk) by a p38 MAPK-dependent pathway. J Biol Chem. 275:25262–25272.
   PubMed Web of Science ®Google Scholar
• Belova L, Sharma S, Brickley DR, Nicolarsen JR, Patterson C, Conzen SD. 2006. Ubiquitin-proteasome degradation of serum- and glucocorticoid-regulated kinase-1 (SGK-1) is mediated by the chaperone-dependent E3 ligase CHIP. Biochem J. 400:235–244.
   PubMed Web of Science ®Google Scholar
• Birkenkamp KU, Coffer PJ. 2003. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans. 31:292–297.
   PubMed Web of Science ®Google Scholar
• Boehmer C, Wilhelm V, Palmada M, Wallisch S, Henke G, Brinkmeier H, Cohen P, Pieske B, Lang F. 2003. Serum and glucocorticoid inducible kinases in the regulation of the cardiac sodium channel SCN5A. Cardiovasc Res. 57:1079–1084.
   PubMed Web of Science ®Google Scholar
• Bogusz AM, Brickley DR, Pew T, Conzen SD. 2006. A novel N-terminal hydrophobic motif mediates constitutive degradation of serum- and glucocorticoid-induced kinase-1 by the ubiquitin-proteasome pathway. FEBS J. 273:2913–2928.
   PubMed Web of Science ®Google Scholar
• Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:857–868.
   PubMed Web of Science ®Google Scholar
• Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME. 2001. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol. 21:952–965.
   PubMed Web of Science ®Google Scholar
• Burgess AW. 2008. EGFR family: Structure physiology signalling and therapeutic targets. Growth Factors. 26:263–274.
   PubMed Web of Science ®Google Scholar
• Buse P, Tran SH, Luther E, Phu PT, Aponte GW, Firestone GL. 1999. Cell cycle and hormonal control of nuclear-cytoplasmic localization of the serum- and glucocorticoid-inducible protein kinase, Sgk, in mammary tumor cells. A novel convergence point of anti-proliferative and proliferative cell signaling pathways. J Biol Chem. 274:7253–7263.
   PubMed Web of Science ®Google Scholar
• Busjahn A, Aydin A, Uhlmann R, Krasko C, Bahring S, Szelestei T, Feng Y, Dahm S, Sharma AM, Luft FC, Lang F. 2002. Serum- and glucocorticoid-regulated kinase (SGK1) gene and blood pressure. Hypertension. 40:256–260.
   PubMed Web of Science ®Google Scholar
• Busjahn A, Seebohm G, Maier G, Toliat MR, Nurnberg P, Aydin A, Luft FC, Lang F. 2004. Association of the serum and glucocorticoid regulated kinase (sgk1) gene with QT interval. Cell Physiol Biochem. 14:135–142.
   PubMedGoogle Scholar
• Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS, Cristiano BE, Pearson RB, Phillips WA. 2004. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res. 64:7678–7681.
   PubMed Web of Science ®Google Scholar
• Cantley LC, Neel BG. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA. 96:4240–4245.
   PubMed Web of Science ®Google Scholar
• Carpten JD, Faber AL, Horn C, Donoho GP, Briggs SL, Robbins CM, Hostetter G, Boguslawski S, Moses TY, Savage S, Uhlik M, Lin A, Du J, Qian YW, Zeckner DJ, Tucker-Kellogg G, Touchman J, Patel K, Mousses S, Bittner M, Schevitz R, Lai MH, Blanchard KL, Thomas JE. 2007. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature. 448:439–444.
   PubMed Web of Science ®Google Scholar
• Carracedo A, Pandolfi PP. 2008. The PTEN-PI3K pathway: Of feedbacks and cross-talks. Oncogene. 27:5527–5541.
   PubMed Web of Science ®Google Scholar
• Chu S, Rushdi S, Zumpe ET, Mamers P, Healy DL, Jobling T, Burger HG, Fuller PJ. 2002. FSH-regulated gene expression profiles in ovarian tumours and normal ovaries. Mol Hum Reprod. 8:426–433.
   PubMed Web of Science ®Google Scholar
• Chun J, Kwon T, Lee EJ, Kim CH, Han YS, Hong SK, Hyun S, Kang SS. 2004. 14-3-3 Protein mediates phosphorylation of microtubule-associated protein tau by serum- and glucocorticoid-induced protein kinase 1. Mol Cells. 18:360–368.
   PubMed Web of Science ®Google Scholar
• Chung EJ, Sung YK, Farooq M, Kim Y, Im S, Tak WY, Hwang YJ, Kim YI, Han HS, Kim JC, Kim MK. 2002. Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. Mol Cells. 14:382–387.
   PubMed Web of Science ®Google Scholar
• Cowling RT, Birnboim HC. 2000. Expression of serum- and glucocorticoid-regulated kinase (sgk) mRNA is up-regulated by GM-CSF and other proinflammatory mediators in human granulocytes. J Leukoc Biol. 67:240–248.
   PubMed Web of Science ®Google Scholar
• Dai F, Yu L, He H, Chen Y, Yu J, Yang Y, Xu Y, Ling W, Zhao S. 2002. Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction. Biochem Biophys Res Commun. 293:1191–1196.
   PubMed Web of Science ®Google Scholar
• Ellson CD, Andrews S, Stephens LR, Hawkins PT. 2002. The PX domain: A new phosphoinositide-binding module. J Cell Sci. 115:1099–1105.
   PubMed Web of Science ®Google Scholar
• Embark HM, Bohmer C, Vallon V, Luft F, Lang F. 2003. Regulation of KCNE1-dependent K(+) current by the serum and glucocorticoid-inducible kinase (SGK) isoforms. Pflugers Arch. 445:601–606.
   PubMed Web of Science ®Google Scholar
• Engelman JA, Luo J, Cantley LC. 2006. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 7:606–619.
   PubMed Web of Science ®Google Scholar
• Engelsberg A, Kobelt F, Kuhl D. 2006. The N-terminus of the serum- and glucocorticoid-inducible kinase Sgk1 specifies mitochondrial localization and rapid turnover. Biochem J. 399:69–76.
   PubMed Web of Science ®Google Scholar
• Failor KL, Desyatnikov Y, Finger LA, Firestone GL. 2007. Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammary epithelial tumor cells. Mol Endocrinol. 21:2403–2415.
   Google Scholar
• Fillon S, Klingel K, Warntges S, Sauter M, Gabrysch S, Pestel S, Tanneur V, Waldegger S, Zipfel A, Viebahn R, Haussinger D, Broer S, Kandolf R, Lang F. 2002. Expression of the serine/threonine kinase hSGK1 in chronic viral hepatitis. Cell Physiol Biochem. 12:47–54.
   PubMedGoogle Scholar
• Firestone GL, Giampaolo JR, O'Keeffe BA. 2003. Stimulus-dependent regulation of serum and glucocorticoid inducible protein kinase (SGK) transcription, subcellular localization and enzymatic activity. Cell Physiol Biochem. 13:1–12.
   PubMed Web of Science ®Google Scholar
• Gamper N, Fillon S, Feng Y, Friedrich B, Lang PA, Henke G, Huber SM, Kobayashi T, Cohen P, Lang F. 2002. K+ channel activation by all three isoforms of serum- and glucocorticoid-dependent protein kinase SGK. Pflugers Arch. 445:60–66.
   PubMed Web of Science ®Google Scholar
• Garcia-Martinez JM, Alessi DR. 2008. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J. 416:375–385.
   PubMed Web of Science ®Google Scholar
• Gassmann P, Haier J, Schluter K, Domikowsky B, Wendel C, Wiesner U, Kubitza R, Engers R, Schneider SW, Homey B, Muller A. 2009. CXCR4 regulates the early extravasation of metastatic tumor cells in vivo. Neoplasia. 11:651–661.
   PubMed Web of Science ®Google Scholar
• Grueneberg DA, Degot S, Pearlberg J, Li W, Davies JE, Baldwin A, Endege W, Doench J, Sawyer J, Hu Y, Boyce F, Xian J, Munger K, Harlow E. 2008. Kinase requirements in human cells: I. Comparing kinase requirements across various cell types. Proc Natl Acad Sci USA. 105:16472–16477.
   PubMed Web of Science ®Google Scholar
• Gulati P, Gaspers LD, Dann SG, Joaquin M, Nobukuni T, Natt F, Kozma SC, Thomas AP, Thomas G. 2008. Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34. Cell Metab. 7:456–465.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell. 100:57–70.
   PubMed Web of Science ®Google Scholar
• Hannan KM, Brandenburger Y, Jenkins A, Sharkey K, Cavanaugh A, Rothblum L, Moss T, Poortinga G, McArthur GA, Pearson RB, Hannan RD. 2003. mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol Cell Biol. 23:8862–8877.
   PubMed Web of Science ®Google Scholar
• Hansen LA, Alexander N, Hogan ME, Sundberg JP, Dlugosz A, Threadgill DW, Magnuson T, Yuspa SH. 1997. Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. Am J Pathol. 150:1959–1975.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Tapping RI, Chao TH, Lo JF, King CC, Yang Y, Lee JD. 2001. BMK1 mediates growth factor-induced cell proliferation through direct cellular activation of serum and glucocorticoid-inducible kinase. J Biol Chem. 276:8631–8634.
   PubMed Web of Science ®Google Scholar
• Hong F, Larrea MD, Doughty C, Kwiatkowski DJ, Squillace R, Slingerland JM. 2008. mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol Cell. 30:701–711.
   PubMed Web of Science ®Google Scholar
• Imaizumi K, Tsuda M, Wanaka A, Tohyama M, Takagi T. 1994. Differential expression of sgk mRNA, a member of the Ser/Thr protein kinase gene family, in rat brain after CNS injury. Brain Res Mol Brain Res. 26:189–196.
   PubMedGoogle Scholar
• Inoki K, Li Y, Zhu T, Wu J, Guan KL. 2002. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol. 4:648–657.
   PubMed Web of Science ®Google Scholar
• Jastrzebski K, Hannan KM, Tchoubrieva EB, Hannan RD, Pearson RB. 2007. Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors. 25:209–226.
   PubMed Web of Science ®Google Scholar
• Jones KT, Greer ER, Pearce D, Ashrafi K. 2009. Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1. PLoS Biol. 7:e60.
   PubMed Web of Science ®Google Scholar
• Kamada Y, Fujioka Y, Suzuki NN, Inagaki F, Wullschleger S, Loewith R, Hall MN, Ohsumi Y. 2005. Tor2 directly phosphorylates the AGC kinase Ypk2 to regulate actin polarization. Mol Cell Biol. 25:7239–7248.
   PubMed Web of Science ®Google Scholar
• Keniry M, Parsons R. 2008. The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene. 27:5477–5485.
   PubMed Web of Science ®Google Scholar
• Klingel K, Warntges S, Bock J, Wagner CA, Sauter M, Waldegger S, Kandolf R, Lang F. 2000. Expression of cell volume-regulated kinase h-sgk in pancreatic tissue. Am J Physiol Gastrointest Liver Physiol. 279:G998–G1002.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Deak M, Morrice N, Cohen P. 1999. Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase. Biochem J. 344 Pt 1: 189–197.
   PubMed Web of Science ®Google Scholar
• Lang F, Klingel K, Wagner CA, Stegen C, Warntges S, Friedrich B, Lanzendorfer M, Melzig J, Moschen I, Steuer S, Waldegger S, Sauter M, Paulmichl M, Gerke V, Risler T, Gamba G, Capasso G, Kandolf R, Hebert SC, Massry SG, Broer S. 2000. Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci USA. 97:8157–8162.
   PubMed Web of Science ®Google Scholar
• Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V. 2006. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev. 86:1151–1178.
   PubMed Web of Science ®Google Scholar
• Lapteva N, Yang AG, Sanders DE, Strube RW, Chen SY. 2005. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther. 12:84–89.
   PubMed Web of Science ®Google Scholar
• Leong ML, Maiyar AC, Kim B, O'Keeffe BA, Firestone GL. 2003. Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J Biol Chem. 278:5871–5882.
   PubMed Web of Science ®Google Scholar
• Liang J, Slingerland JM. 2003. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle. 2:339–345.
   PubMed Web of Science ®Google Scholar
• Lister K, Autelitano DJ, Jenkins A, Hannan RD, Sheppard KE. 2006. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: A possible role for SGK1. Cardiovasc Res. 70:555–565.
   PubMed Web of Science ®Google Scholar
• Liu D, Yang X, Songyang Z. 2000. Identification of CISK, a new member of the SGK kinase family that promotes IL-3-dependent survival. Curr Biol. 10:1233–1236.
   PubMed Web of Science ®Google Scholar
• Liu P, Cheng H, Roberts TM, Zhao JJ. 2009. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov. 8:627–644.
   PubMed Web of Science ®Google Scholar
• Lu M, Wang J, Jones KT, Ives HE, Feldman ME, Yao LJ, Shokat KM, Ashrafi K, Pearce D. 2010. mTOR complex-2 activates ENaC by phosphorylating SGK1. J Am Soc Nephrol. 21:811–818.
   PubMed Web of Science ®Google Scholar
• Ma XM, Blenis J. 2009. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 10:307–318.
   PubMed Web of Science ®Google Scholar
• Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. 2005. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell. 121:179–193.
   PubMed Web of Science ®Google Scholar
• Maier G, Palmada M, Rajamanickam J, Shumilina E, Bohmer C, Lang F. 2006. Upregulation of HERG channels by the serum and glucocorticoid inducible kinase isoform SGK3. Cell Physiol Biochem. 18:177–186.
   PubMedGoogle Scholar
• Maiyar AC, Huang AJ, Phu PT, Cha HH, Firestone GL. 1996. p53 stimulates promoter activity of the sgk. serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells. J Biol Chem. 271:12414–12422.
   PubMed Web of Science ®Google Scholar
• Manning BD, Cantley LC. 2007. AKT/PKB signaling: Navigating downstream. Cell. 129:1261–1274.
   PubMed Web of Science ®Google Scholar
• Mayer C, Zhao J, Yuan X, Grummt I. 2004. mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev. 18:423–434.
   PubMed Web of Science ®Google Scholar
• McCormick JA, Feng Y, Dawson K, Behne MJ, Yu B, Wang J, Wyatt AW, Henke G, Grahammer F, Mauro TM, Lang F, Pearce D. 2004. Targeted disruption of the protein kinase SGK3/CISK impairs postnatal hair follicle development. Mol Biol Cell. 15:4278–4288.
   PubMed Web of Science ®Google Scholar
• Meng F, Yamagiwa Y, Taffetani S, Han J, Patel T. 2005. IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway. Am J Physiol Cell Physiol. 289:C971–C981.
   PubMed Web of Science ®Google Scholar
• Mikosz CA, Brickley DR, Sharkey MS, Moran TW, Conzen SD. 2001. Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1. J Biol Chem. 276:16649–16654.
   PubMed Web of Science ®Google Scholar
• Mizuno H, Nishida E. 2001. The ERK MAP kinase pathway mediates induction of SGK (serum- and glucocorticoid-inducible kinase) by growth factors. Genes Cells. 6:261–268.
   PubMed Web of Science ®Google Scholar
• Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50–56.
   PubMed Web of Science ®Google Scholar
• Murray JT, Campbell DG, Morrice N, Auld GC, Shpiro N, Marquez R, Peggie M, Bain J, Bloomberg GB, Grahammer F, Lang F, Wulff P, Kuhl D, Cohen P. 2004. Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. Biochem J. 384:477–488.
   PubMed Web of Science ®Google Scholar
• Palmada M, Embark HM, Yun C, Bohmer C, Lang F. 2003. Molecular requirements for the regulation of the renal outer medullary K(+) channel ROMK1 by the serum- and glucocorticoid-inducible kinase SGK1. Biochem Biophys Res Commun. 311:629–634.
   PubMed Web of Science ®Google Scholar
• Palmada M, Dieter M, Boehmer C, Waldegger S, Lang F. 2004. Serum and glucocorticoid inducible kinases functionally regulate ClC-2 channels. Biochem Biophys Res Commun. 321:1001–1006.
   Web of Science ®Google Scholar
• Pao AC, McCormick JA, Li H, Siu J, Govaerts C, Bhalla V, Soundararajan R, Pearce D. 2007. NH2 terminus of serum and glucocorticoid-regulated kinase 1 binds to phosphoinositides and is essential for isoform-specific physiological functions. Am J Physiol Renal Physiol. 292:F1741–F1750.
   PubMed Web of Science ®Google Scholar
• Park J, Leong ML, Buse P, Maiyar AC, Firestone GL, Hemmings BA. 1999. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J. 18:3024–3033.
   PubMed Web of Science ®Google Scholar
• Perrotti N, He RA, Phillips SA, Haft CR, Taylor SI. 2001. Activation of serum- and glucocorticoid-induced protein kinase (Sgk) by cyclic AMP and insulin. J Biol Chem. 276:9406–9412.
   PubMedGoogle Scholar
• Philp AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH, Thomas RJ, Phillips WA. 2001. The phosphatidylinositol 3′-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res. 61:7426–7429.
   PubMed Web of Science ®Google Scholar
• Potter CJ, Pedraza LG, Xu T. 2002. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol. 4:658–665.
   PubMed Web of Science ®Google Scholar
• Rangone H, Poizat G, Troncoso J, Ross CA, MacDonald ME, Saudou F, Humbert S. 2004. The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin. Eur J Neurosci. 19:273–279.
   PubMed Web of Science ®Google Scholar
• Rauhala HE, Porkka KP, Tolonen TT, Martikainen PM, Tammela TL, Visakorpi T. 2005. Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer. Int J Cancer. 117:738–745.
   PubMed Web of Science ®Google Scholar
• Richards JS, Sharma SC, Falender AE, Lo YH. 2002. Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: Evidence for regulation by IGF-I, estrogen, and the gonadotropins. Mol Endocrinol. 16:580–599.
   PubMedGoogle Scholar
• Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 370:527–532.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, Waterfield MD, Downward J. 1996. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 15:2442–2451.
   PubMed Web of Science ®Google Scholar
• Sakoda H, Gotoh Y, Katagiri H, Kurokawa M, Ono H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Fukushima Y, Abe M, Shojima N, Kikuchi M, Oka Y, Hirai H, Asano T. 2003. Differing roles of Akt and serum- and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem. 278:25802–25807.
   PubMed Web of Science ®Google Scholar
• Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE. 2004. High frequency of mutations of the PIK3CA gene in human cancers. Science. 304:554.
   PubMed Web of Science ®Google Scholar
• Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, Sabatini DM. 2008. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science. 320:1496–1501.
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 307:1098–1101.
   PubMed Web of Science ®Google Scholar
• Schwab M, Lupescu A, Mota M, Mota E, Frey A, Simon P, Mertens PR, Floege J, Luft F, Asante-Poku S, Schaeffeler E, Lang F. 2008. Association of SGK1 gene polymorphisms with type 2 diabetes. Cell Physiol Biochem. 21:151–160.
   PubMedGoogle Scholar
• Seebohm G, Strutz-Seebohm N, Ureche ON, Henrion U, Baltaev R, Mack AF, Korniychuk G, Steinke K, Tapken D, Pfeufer A, Kaab S, Bucci C, Attali B, Merot J, Tavare JM, Hoppe UC, Sanguinetti MC, Lang F. 2008. Long QT syndrome-associated mutations in KCNQ1 and KCNE1 subunits disrupt normal endosomal recycling of IKs channels. Circ Res. 103:1451–1457.
   PubMedGoogle Scholar
• Shaw RJ. 2009. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol (Oxf). 196:65–80.
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Cantley LC. 2006. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. 441:424–430.
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA, Cantley LC. 2004. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell. 6:91–99.
   PubMed Web of Science ®Google Scholar
• Sibilia M, Wagner EF. 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:234–238.
   PubMed Web of Science ®Google Scholar
• Slagsvold T, Marchese A, Brech A, Stenmark H. 2006. CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4. EMBO J. 25:3738–3749.
   PubMed Web of Science ®Google Scholar
• Snyder PM, Olson DR, Thomas BC. 2002. Serum and glucocorticoid-regulated kinase modulates Nedd4-2-mediated inhibition of the epithelial Na+ channel. J Biol Chem. 277:5–8.
   PubMed Web of Science ®Google Scholar
• Sofer A, Lei K, Johannessen CM, Ellisen LW. 2005. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol. 25:5834–5845.
   PubMed Web of Science ®Google Scholar
• Solomon B, Pearson RB. 2009. Class IA phosphatidylinositol 3-kinase signaling in non-small cell lung cancer. J Thorac Oncol. 4:787–791.
   PubMed Web of Science ®Google Scholar
• Soukas AA, Kane EA, Carr CE, Melo JA, Ruvkun G. 2009. Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans. Genes Dev. 23:496–511.
   PubMed Web of Science ®Google Scholar
• Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, Carey M, Hu Z, Guan Y, Sahin A, Symmans WF, Pusztai L, Nolden LK, Horlings H, Berns K, Hung MC, van de Vijver MJ, Valero V, Gray JW, Bernards R, Mills GB, Hennessy BT. 2008. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res. 68:6084–6091.
   PubMed Web of Science ®Google Scholar
• Strutz-Seebohm N, Seebohm G, Korniychuk G, Baltaev R, Ureche O, Striegel M, Lang F. 2006. Additive regulation of GluR1 by stargazin and serum- and glucocorticoid-inducible kinase isoform SGK3. Pflugers Arch. 452:276–282.
   PubMed Web of Science ®Google Scholar
• Tai DJ, Su CC, Ma YL, Lee EH. 2009. SGK1 phosphorylation of IkappaB Kinase alpha and p300 Up-regulates NF-kappaB activity and increases N-Methyl-D-aspartate receptor NR2A and NR2B expression. J Biol Chem. 284:4073–4089.
   PubMed Web of Science ®Google Scholar
• Tessier M, Woodgett JR. Role of the Phox homology domain and phosphorylation in activation of serum and glucocorticoid-regulated kinase-3. J Biol Chem. 2006a; 281:23978–23989.
   PubMed Web of Science ®Google Scholar
• Tessier M, Woodgett JR. Serum and glucocorticoid-regulated protein kinases: Variations on a theme. J Cell Biochem. 2006b; 98:1391–1407.
   PubMed Web of Science ®Google Scholar
• Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, . 1995. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype. Science. 269 (5221): 230–234.
   PubMed Web of Science ®Google Scholar
• Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH. 2007. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol. 9:316–323.
   PubMed Web of Science ®Google Scholar
• Vasudevan KM, Burikhanov R, Goswami A, Rangnekar VM. 2007. Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras. Cancer Res. 67:10343–10350.
   PubMed Web of Science ®Google Scholar
• Vasudevan KM, Barbie DA, Davies MA, Rabinovsky R, McNear CJ, Kim JJ, Hennessy BT, Tseng H, Pochanard P, Kim SY, Dunn IF, Schinzel AC, Sandy P, Hoersch S, Sheng Q, Gupta PB, Boehm JS, Reiling JH, Silver S, Lu Y, Stemke-Hale K, Dutta B, Joy C, Sahin AA, Gonzalez-Angulo AM, Lluch A, Rameh LE, Jacks T, Root DE, Lander ES, Mills GB, Hahn WC, Sellers WR, Garraway LA. 2009. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell. 16:21–32.
   PubMed Web of Science ®Google Scholar
• Virbasius JV, Song X, Pomerleau DP, Zhan Y, Zhou GW, Czech MP. 2001. Activation of the Akt-related cytokine-independent survival kinase requires interaction of its phox domain with endosomal phosphatidylinositol 3-phosphate. Proc Natl Acad Sci USA. 98:12908–12913.
   PubMed Web of Science ®Google Scholar
• Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2:489–501.
   PubMed Web of Science ®Google Scholar
• Waldegger S, Barth P, Raber G, Lang F. 1997. Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc Natl Acad Sci USA. 94:4440–4445.
   PubMed Web of Science ®Google Scholar
• Waldegger S, Klingel K, Barth P, Sauter M, Rfer ML, Kandolf R, Lang F. 1999. h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology. 116:1081–1088.
   PubMed Web of Science ®Google Scholar
• Wandzioch E, Edling CE, Palmer RH, Carlsson L, Hallberg B. 2004. Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines. Blood. 104:51–57.
   PubMed Web of Science ®Google Scholar
• Wang Y, Pennock S, Chen X, Wang Z. 2002. Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol Cell Biol. 22:7279–7290.
   PubMed Web of Science ®Google Scholar
• Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL. 1993. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol. 13:2031–2040.
   PubMed Web of Science ®Google Scholar
• Won M, Park KA, Byun HS, Kim YR, Choi BL, Hong JH, Park J, Seok JH, Lee YH, Cho CH, Song IS, Kim YK, Shen HM, Hur GM. 2009. Protein kinase SGK1 enhances MEK/ERK complex formation through the phosphorylation of ERK2: Implication for the positive regulatory role of SGK1 on the ERK function during liver regeneration. J Hepatol. 51:67–76.
   PubMed Web of Science ®Google Scholar
• von Wowern F, Berglund G, Carlson J, Mansson H, Hedblad B, Melander O. 2005. Genetic variance of SGK-1 is associated with blood pressure, blood pressure change over time and strength of the insulin-diastolic blood pressure relationship. Kidney Int. 68:2164–2172.
   PubMed Web of Science ®Google Scholar
• Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD. 2004. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res. 64:1757–1764.
   PubMed Web of Science ®Google Scholar
• Wu W, Zou M, Brickley DR, Pew T, Conzen SD. 2006. Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells. Mol Endocrinol. 20:2304–2314.
   PubMedGoogle Scholar
• Wullschleger S, Loewith R, Hall MN. 2006. TOR signaling in growth and metabolism. Cell. 124:471–484.
   PubMed Web of Science ®Google Scholar
• Wyatt AW, Hussain A, Amann K, Klingel K, Kandolf R, Artunc F, Grahammer F, Huang DY, Vallon V, Kuhl D, Lang F. 2006. DOCA-induced phosphorylation of glycogen synthase kinase 3beta. Cell Physiol Biochem. 17:137–144.
   PubMedGoogle Scholar
• Xia D, Srinivas H, Ahn YH, Sethi G, Sheng X, Yung WK, Xia Q, Chiao PJ, Kim H, Brown PH, Wistuba II, Aggarwal BB, Kurie JM. 2007. Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. J Biol Chem. 282:3507–3519.
   PubMed Web of Science ®Google Scholar
• Xing Y, Liu D, Zhang R, Joachimiak A, Songyang Z, Xu W. 2004. Structural basis of membrane targeting by the Phox homology domain of cytokine-independent survival kinase (CISK-PX). J Biol Chem. 279:30662–30669.
   PubMed Web of Science ®Google Scholar
• Xu J, Liu D, Gill G, Songyang Z. 2001. Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides. J Cell Biol. 154:699–705.
   PubMed Web of Science ®Google Scholar
• Xu J, Liao L, Qin J, Liu D, Songyang Z. 2009. Identification of Flightless-I as a substrate of the cytokine-independent survival kinase CISK. J Biol Chem. 284:14377–14385.
   PubMed Web of Science ®Google Scholar
• Yuan TL, Cantley LC. 2008. PI3K pathway alterations in cancer: Variations on a theme. Oncogene. 27:5497–5510.
   PubMed Web of Science ®Google Scholar
• Zhang BH, Tang ED, Zhu T, Greenberg ME, Vojtek AB, Guan KL. 2001. Serum- and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf. J Biol Chem. 276:31620–31626.
   PubMed Web of Science ®Google Scholar
• Zhang L, Cui R, Cheng X, Du J. 2005. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I{kappa}B kinase. Cancer Res. 65:457–464.
   PubMed Web of Science ®Google Scholar
• Zhou R, Snyder PM. 2005. Nedd4-2 phosphorylation induces serum and glucocorticoid-regulated kinase (SGK) ubiquitination and degradation. J Biol Chem. 280:4518–4523.
   PubMed Web of Science ®Google Scholar